# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-074673
Filing Date
2021-06-01
Accepted
2021-06-01 08:55:45
Documents
5
Period of Report
2021-05-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | tm2118054d1_6k.htm | 6-K | 22584
2 | GRAPHIC | tm2118054d1_6kimg001.jpg | GRAPHIC | 321133
3 | GRAPHIC | tm2118054d1_6kimg002.jpg | GRAPHIC | 324599
4 | GRAPHIC | tm2118054d1_6kimg003.jpg | GRAPHIC | 321357
5 | GRAPHIC | tm2118054d1_6kimg004.jpg | GRAPHIC | 83368
| Complete submission text file | 0001104659-21-074673.txt |  | 1451811

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 21983238
SIC: 2834 Pharmaceutical Preparations